4
Changes in Ownership
AXIM BIOTECHNOLOGIES, INC. Filed Acc 0001096906-24-000511
Options or other derivatives
- Chief Financial Officer acquired 53,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| MALASEK ROBERT Chief Financial Officer | 2024-03-15 | Grant or award · Convertible Note | +53,500 | $53,500.00 | $2,862,250,000 | 3,475,000 | D |
Loading xslF345X05/form4.xml…